Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT)

被引:2
|
作者
Kaptanoglu, Asli Feride
Uncu, Murat
Ozyurt, Selcuk
Hincal, Evren
机构
[1] Near East Univ Hosp, Dept Dermatol, Lefkosa, North Cyprus, Turkey
[2] Near East Univ Hosp, Dept Biochem, Lefkosa, North Cyprus, Turkey
[3] Ataturk Res & Educ Hosp, Dept Dermatol, Izmir, Turkey
[4] Near East Univ, Fac Arts & Sci, Dept Math, Lefkosa, North Cyprus, Turkey
关键词
isotretinoin; side effects; prothrombin time; activated partial thromboplastin time; coagulation; surgery; ROUTINE BLOOD-TESTS; ACNE-VULGARIS; HEMOPHILIA-A; THROMBOCYTOPENIA; THERAPY; FIBRINOLYSIS; GUIDELINES;
D O I
10.3109/09546634.2011.652063
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Patients with severe acne may need elective/urgent surgical interventions during treatment with isotretinoin and it is critical for the surgeon to consider the possible effects of this medication on coagulation systems. The aim of this study is to determine the changes in prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT) during isotretinoin treatment. PT, aPTT, and INR values of 51 severe acne patients were evaluated during routine pretreatment biochemical analysis. Only patients with normal values were included in the study. The results of before and after 1 month treatment were compared statistically. There were no statistically significant change in mean alanine aminotranferease (ALT), aspartate aminotransferase (AST), PT, and INR values after treatment. A significant increase in aPTT was detected. The INR values, which are more trusted and safe, showed no difference. Isotretinoin seems to have no effect on these coagulation parameters.
引用
收藏
页码:272 / 274
页数:3
相关论文
共 50 条
  • [41] Verification and Establishment of Reference Intervals for Prothrombin Time and Activated Partial Thromboplastin Time for Children in a Clinical Laboratory
    Lee, Min Young
    Lee, Woo In
    Kang, So Young
    Kim, Myeong Hee
    CLINICAL LABORATORY, 2022, 68 (02) : 367 - 373
  • [42] Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform Analysis
    Kato, Konami
    Hatayama, Yuki
    Shimohiro, Hisashi
    Ichikawa, Hitomi
    Fukuda, Tetsuya
    YONAGO ACTA MEDICA, 2022, 65 (03) : 226 - 230
  • [43] Assessment of prothrombin time, activated partial thromboplastin time, and fibrinogen concentration on equine plasma samples following different storage conditions
    Casella, Stefania
    Giannetto, Claudia
    Fazio, Francesco
    Giudice, Elisabetta
    Piccione, Giuseppe
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2009, 21 (05) : 674 - 678
  • [44] THE INFLUENCE OF THE REFERENCE MEAN PROTHROMBIN TIME ON THE INTERNATIONAL NORMALIZED RATIO
    CRITCHFIELD, GC
    BENNETT, ST
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 102 (06) : 806 - 811
  • [45] Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method
    Chen, Jian
    Phillips, Bonnie
    Chandler, Wayne L.
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (01) : 90 - 96
  • [46] Prothrombin time, activated partial thromboplastin time and platelet counts of type II diabetes mellitus: a comparative study
    Ambelu Y.A.
    Shiferaw M.B.
    Abebe M.
    Enawgaw B.
    Journal of Diabetes & Metabolic Disorders, 2018, 17 (2) : 117 - 121
  • [47] Restoration of Normal Prothrombin Time/International Normalized Ratio With Fresh Frozen Plasma in Hypocoagulable Patients
    Only, Arthur J., Jr.
    DeChristopher, Phillip J.
    Iqal, Omer
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (01) : 85 - 91
  • [48] Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers
    Michael P. Ero
    Nathaniel R. Harvey
    Jack L. Harbert
    James W. Janc
    Kay H. Chin
    Steven L. Barriere
    Journal of Thrombosis and Thrombolysis, 2014, 38 : 235 - 240
  • [49] Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers
    Ero, Michael P.
    Harvey, Nathaniel R.
    Harbert, Jack L.
    Janc, James W.
    Chin, Kay H.
    Barriere, Steven L.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (02) : 235 - 240
  • [50] Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population
    Zhang, Fan
    Mu, Guangyan
    Liu, Zhiyan
    Xie, Qiufen
    Zhang, Hanxu
    Zhou, Shuang
    Wang, Zhe
    Hu, Kun
    Wang, Zining
    Zhao, Xia
    Cui, Yimin
    Xiang, Qian
    GENES, 2022, 13 (10)